Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ALK signs PRE-PEN supply contract with HealthTrust
HealthTrust will include the PRE-PEN skin test, used for the diagnosis of penicillin allergy, to help reduce the unnecessary use of toxic, broad spectrum antibiotics, which are known
HealthTrust will include the PRE-PEN skin test, used for the diagnosis of penicillin allergy, to help reduce the unnecessary use of toxic, broad spectrum antibiotics, which are known
The collaboration leverages Theraclone I-STAR technology, which is used to screen and identify novel human antibodies to pathogenic agents and endogenous therapeutic targets, to discover monoclonal antibodies against
Under the contract, SPAR, which is providing in-store merchandising and demonstrative services to marquee clients such as Grupo Herdez, McCormick, BIC, Tramontina, Epson, Levi Strauss, Olympus and 20th
The NRC researchers will use the money for a pilot development project to manufacture IL-17E. The NRC-IRAP funds will also allow Lorus to access knowledge and capabilities combined
Hypoxia is a physiological state with reduced oxygen levels that impacts metabolism, angiogenesis, vasodilation and erythropoiesis through the HIF1a transcription factor. Hypoxia and the subsequent accumulation of HIF1a
The placebo-controlled randomised study met the primary endpoint by reducing mean daily pain score versus placebo over the last week of 28 days of treatment. According to study
US FDA during its inspection, reviewed the certification reports for manufacturing of Carvedilol and aramomycin. The US FDA has issued operational clearence, based on the corrective actions taken
Cuvposa is an inhibitor of acetylcholine receptors located on certain peripheral tissues such as salivary glands, which cause reduction in the rate of salivation. Cerebral palsy (CP) is
Rockwell chairman and CEO Robert Chioini said the patent gives additional protection to the method and pharmaceutical composition. "Also, this patent further strengthens our overall IP portfolio for
The double-blind, randomised study is being conducted under a cooperative research and development agreement between Aeterna Zentaris and the Michael E. DeBakey Veterans Affairs Medical Center. The study